Capricor's Duchenne drug gets three-month FDA extension after new data submission - Reuters

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxOX19EdUx2UzY4ZVFfdF…; target="_blank">Capricor's Duchenne drug gets three-month FDA extension after new data submission</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>